GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Market Cap

Moberg Pharma AB (OSTO:MOB) Market Cap : kr668.28 Mil (As of May. 28, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Moberg Pharma AB's share price for the quarter that ended in Mar. 2024 was kr22.6. Moberg Pharma AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 27.96 Mil. Therefore, Moberg Pharma AB's market cap for the quarter that ended in Mar. 2024 was kr631.93 Mil.

Moberg Pharma AB's quarterly market cap increased from Sep. 2023 (kr176.16 Mil) to Dec. 2023 (kr425.01 Mil) and increased from Dec. 2023 (kr425.01 Mil) to Mar. 2024 (kr631.93 Mil).

Moberg Pharma AB's annual market cap declined from Dec. 2021 (kr236.53 Mil) to Dec. 2022 (kr227.99 Mil) but then increased from Dec. 2022 (kr227.99 Mil) to Dec. 2023 (kr425.01 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Moberg Pharma AB's Enterprise Value for Today is kr634.07 Mil.


Moberg Pharma AB Market Cap Historical Data

The historical data trend for Moberg Pharma AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Market Cap Chart

Moberg Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 761.26 150.38 236.53 227.99 425.01

Moberg Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 267.29 87.46 176.16 425.01 631.93

Competitive Comparison of Moberg Pharma AB's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Market Cap falls into.



Moberg Pharma AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Moberg Pharma AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr15.2*27.9615
=kr425.01

Moberg Pharma AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=kr22.6*27.9615
=kr631.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moberg Pharma AB  (OSTO:MOB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Moberg Pharma AB Market Cap Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB (OSTO:MOB) Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.